- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Georgetown University's Alan Faden, a finalist for the position of institute director, is the third candidate to visit campus
Alan I. Faden, M.D., a professor of neuroscience at Georgetown University, will share his vision for UC Riverside's Health Sciences Research Institute (HSRI) in an open forum on campus at 4 p.m., Monday, March 26, in the Statistics Building, room B650.
The HSRI, which aims to strengthen and focus research and graduate education in the biomedical and health sciences on campus, is in the process of recruiting its founding director. Faden, the founding director of the Georgetown Institute for Cognitive and Computational Sciences, is the third finalist to visit campus, after Dartmouth Medical School's Randolph J. Noelle and La Jolla Institute for Allergy and Immunology's Carl Ware.
"The HSRI should establish an internationally recognized research program that expands and complements biomedical research at UC Riverside; that enhances and provides new educational opportunities at the undergraduate and graduate level; and that helps to create the academic base to support a highly competitive four year medical school," Faden said. "Proposed areas of focus would be neuroscience and oncology, with connecting sub-themes related to aging and development."
According to Dr. Faden's vision, major HSRI research topics would include neurodegeneration, neuroplasticity and regeneration, as well as stem cell biology. Key technology areas would be enhanced or developed to support the research effort and to facilitate interdisciplinary collaborations, including systems biology, nanotechnology, molecular imaging, and medicinal chemistry.
Dr. Faden's vision includes also an emphasis on establishing strategic partnerships with other universities, industry and government to maximize the effectiveness and productivity of the new institute, as well as to promote the translational potential of its research.
"Dr Faden is a world-renowned neurologist with over 300 peer-reviewed science publications," said Ameae Walker, a professor of biomedical sciences and co-chair, along with Michael Pirrung, professor of chemistry, of the search committee for the HSRI director. "His extensive administrative experience and superb scholarship qualify him as an outstanding candidate."
From 1991-1996, Dr. Faden served as the first dean of research at Georgetown University School of Medicine, and as scientific director of the Medical Center. At Georgetown, he also was associate dean for biomedical sciences in the Graduate School, and directed the M.D./Ph.D. program.
Before joining Georgetown, Dr. Faden was a professor and vice-chair of the Department of Neurology at UC San Francisco, as well as chief of neurology at the Veterans Administration Medical Center and director of the Center for Neural Injury. Currently, he is the president of the American Society for Experimental NeuroTherapeutics.
Dr. Faden's research interests include molecular/cellular neuroscience and genomics related to cell death and neurodegeneration, with a strong translational component that includes drug discovery.
The HSRI aims to bring together researchers from all sectors of health research to help produce ground-breaking discoveries in biomedical/health research. The vision for the institute includes association with the proposed UCR medical school that would attract strong clinical researchers and offer unique graduate and professional programs in health.
Other finalists for the position of HSRI Director, each of whom will present seminars on his/her vision for the institute are: Jean Schwarzbauer, professor of molecular biology, Princeton University, April 9; and Richard Bergman, Keck Professor of Medicine (physiology and biophysics), University of Southern California, April 11. Both vision seminars will take at 4 p.m. at campus locations to be determined.
For further information, contact Felecia Wilson, in the Office of Executive Searches, at 951-827-5080.
About University of California, Riverside
The University of California, Riverside is a doctoral research university, a living laboratory for groundbreaking exploration of issues critical to Inland Southern California, the state and communities around the world. Reflecting California's diverse culture, UCR's enrollment of about 17,000 is projected to grow to 21,000 students by 2010. The campus is proposing a medical school and already has reached the heart of the Coachella Valley by way of the UCR Palm Desert Graduate Center. With an annual statewide economic impact of nearly $1 billion, UCR is actively shaping the region's future. To learn more, visit www.ucr.edu or call (951) UCR-NEWS.
For more information, please click here
News Media Contact:
Name: Iqbal Pittalwala
Copyright © University of California, RiversideIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Oxford Nanoimaging report on how the Nanoimager, a desktop microscope delivering single molecule, super-resolution performance, is being applied at the MRC Centre for Molecular Bacteriology & Infection November 22nd, 2016
New Agricultural Research Center Debuts at UCF October 12th, 2016
Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D: Up-close, real-time, chemical-sensitive 3-D imaging offers clues for reducing cost/improving performance of catalysts for fuel-cell-powered vehicles and other applications December 8th, 2016
Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016
IEDM: Leti CEO Marie Semeria to Give Opening-day Keynote on Impact of ‘Hyperconnectivity’ and IoT: Speech to Portray Key Role Nonprofit Research and Technology Organizations Play in Making Technology More Efficient and Ensuring Safety and Security November 29th, 2016